Abbott, Tandem Diabetes Care Partner For Glucose-Ketone Sensor for Diabetes Management
Abbott Laboratories (NYSE:ABT) is one of the best stocks to buy for beginners now. On June 10, Tandem Diabetes Care Inc.
Tandem Diabetes Care Inc (TNDM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sessa Capital John Petry | 4,466,307 | $85,574,442 | 3.34% | |
| 2. | Hood River Capital Management David Swank | 2,312,044 | $44,298,763 | +81% | 0.76% |
| 3. | Paradice Investment Management David Paradice | 1,649,907 | $31,612,218 | +73% | 7.06% |
| 4. | Park West Asset Management Peter S. Park | 1,123,052 | $21,517,676 | -30% | 1.74% |
| 5. | 19,597,000 | $18,421,180 | 0.48% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.12 | 10,538 | $190,966.47 | 10,538 | 2025-03-07 | Filing | |
| $23.24 | 532 | $12,363.68 | 532 | 2024-11-15 | Filing | |
| $18.96 | 5,000 | $94,777.50 | 19,962 | 2023-11-27 | Filing | |
| $15.39 | 6,200 | $95,395.06 | 11,860 | 2023-11-08 | Filing | |
| $15.44 | 1,935 | $29,884.33 | 1,935 | 2023-11-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $31.38 | 30,000 | $941,400.00 | 165,190 | 2024-11-21 | Filing | |
| $30.00 | 10,000 | $300,000.00 | 195,190 | 2024-11-20 | Filing | |
| $51.68 | 5,000 | $258,400.00 | 0 | 2024-05-30 | Filing | |
| $41.19 | 10,000 | $411,884.00 | 3,365 | 2023-03-03 | Filing | |
| $40.25 | 10,000 | $402,500.00 | 3,029 | 2022-12-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,028,712 | $211,310,121 | 0% | |
| 2. | 7,292,169 | $139,717,957 | 0% | |
| 3. | 145,356,000 | $137,329,421 | 0.93% | |
| 4. | Ubs Group AgCALL | 2,745,312 | $52,600,178 | 0.01% |
| 5. | 2,716,332 | $52,044,921 | 0.84% |
News See All
Do You Believe in the Long-Term Growth Potential of Tandem Diabetes Care (TNDM)?
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” first quarter 2025 investor letter.
Tandem Diabetes and Roche Reach a Patent Settlement
The deal settles all pending and prospective litigation about two European patents that Roche filed in December 2023, EP 2 196 231 B1 and EP 1 970 677 B1.
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Tandem Diabetes Care First Quarter 2025 Earnings Conference Call. At this time, all participants are on a listen-only mode.
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q4 2024 Earnings Call Transcript
Operator: Good day and welcome to the Tandem Diabetes Fourth Quarter and Year-End 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Tandem Diabetes Care (TNDM) Slid in Q4 Despite Strong Results
Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Oversold Healthcare Stocks To Invest In
Investing in healthcare stocks during lean economic times is generally regarded as defensive.
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q3 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Tandem Diabetes Care Q3 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to Tandem Diabetes Care Quarter 2 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2024 Earnings Call Transcript
Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0.65387, expectations were $-0.8. Tandem Diabetes Care, Inc.
Billionaire Hedge Funds
